Lyell Immunopharma

investment firm

Investments

Number of Investments
Number of Lead Investments
6
2
Lyell Immunopharma has made 6 investments. Their most recent investment was on Mar 31, 2021, when Outpace Bio, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Mar 31, 2021 Outpace Bio Series A — Biotechnology Yes
Sep 30, 2020 Sonoma Pharmaceuticals Post-IPO Equity — Health Care —
Sep 30, 2020 Sonoma BioTherapeutics Series A — Biotechnology —
Mar 18, 2020 Cero Therapeutics Series A — Biotechnology —
Mar 17, 2020 Eureka Therapeutics Series E — Biotechnology Yes
Feb 6, 2020 Sonoma BioTherapeutics Series A — Biotechnology —